Sutro Biopharma Inc (STRO) stock has gained 118.11% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives STRO stock a score of 66 out of a possible 100.
That rank is influenced by a long-term technical score of 95. STRO's rank also includes a short-term technical score of 72. The fundamental score for STRO is 29. In addition to the average rating from Wall Street analysts, STRO stock has a mean target price of 27.833. This means analysts expect the stock to climb 6.52% over the next 12 months.
What's Happening with STRO Stock Today
Sutro Biopharma Inc (STRO) stock is down -0.76% while the S&P 500 has gained 0.02% as of 1:18 PM on Thursday, Jan 21. STRO is lower by -$0.20 from the previous closing price of $26.33 on volume of 395,477 shares. Over the past year the S&P 500 has gained 15.98% while STRO has gained 118.11%. STRO lost -$0.09 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Sutro Biopharma Inc (STRO) Stock.
